Literature DB >> 36216873

Boosting cytotoxic T cells for immunotherapy.

Alexandra Flemming1.   

Abstract

Entities:  

Year:  2022        PMID: 36216873     DOI: 10.1038/s41577-022-00793-2

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   108.555


× No keyword cloud information.
  2 in total

1.  PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program.

Authors:  Masao Hashimoto; Koichi Araki; Maria A Cardenas; Peng Li; Rohit R Jadhav; Haydn T Kissick; William H Hudson; Donald J McGuire; Rebecca C Obeng; Andreas Wieland; Judong Lee; Daniel T McManus; James L Ross; Se Jin Im; Junghwa Lee; Jian-Xin Lin; Bin Hu; Erin E West; Christopher D Scharer; Gordon J Freeman; Arlene H Sharpe; Suresh S Ramalingam; Alex Pellerin; Volker Teichgräber; William J Greenleaf; Christian Klein; Jorg J Goronzy; Pablo Umaña; Warren J Leonard; Kendall A Smith; Rafi Ahmed
Journal:  Nature       Date:  2022-09-28       Impact factor: 69.504

2.  PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.

Authors:  Laura Codarri Deak; Valeria Nicolini; Masao Hashimoto; Maria Karagianni; Petra C Schwalie; Laura Lauener; Eleni Maria Varypataki; Marine Richard; Esther Bommer; Johannes Sam; Stefanie Joller; Mario Perro; Floriana Cremasco; Leo Kunz; Emilio Yanguez; Tamara Hüsser; Ramona Schlenker; Marisa Mariani; Vinko Tosevski; Sylvia Herter; Marina Bacac; Inja Waldhauer; Sara Colombetti; Xavier Gueripel; Stephan Wullschleger; Melanie Tichet; Douglas Hanahan; Haydn T Kissick; Stephane Leclair; Anne Freimoser-Grundschober; Stefan Seeber; Volker Teichgräber; Rafi Ahmed; Christian Klein; Pablo Umaña
Journal:  Nature       Date:  2022-09-28       Impact factor: 69.504

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.